NeuroSense Therapeutics Ltd. (NRSN) — Institutional Holders, Q2 2026
14 institutional investment managers reported a NRSN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $296.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NRSN in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- UBS Group AGAdded · +59,540 sh+$42.9K
- Independent Advisor AllianceAdded · +50,000 sh+$36.0K
- XTX Topco LtdNew · +11,473 sh+$8.3K
- HRT FINANCIALNew · +10,515 sh+$7.6K
Biggest sellers
- TWO SIGMA INVESTMENTSSold out · -44,445 sh-$32.0K
- MEITAV INVESTMENT HOUSE LTDSold out · -40,000 sh-$28.8K
- JANE STREET GROUPSold out · -28,670 sh-$20.6K
- Creative PlanningTrimmed · -501 sh-$361.00
- SBI Securities , Ltd.Trimmed · -10 sh-$7.00
NRSN 13F holders ranked 1–14 of 14
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | UBS Group AG#1 · 109,799 sh | 109,799 | $78.3K | 0.00% | +118.5% |
| 2 | Independent Advisor Alliance#2 · 100,000 sh | 100,000 | $72.0K | <0.01% | +100.0% |
| 3 | Yorkville Advisors Global#3 · 78,000 sh | 78,000 | $56.2K | 0.07% | 0.0% |
| 4 | COMMONWEALTH EQUITY SERVICES#4 · 22,775 sh | 22,775 | $16.4K | 0.00% | 0.0% |
| 5 | PNC FINANCIAL SERVICES GROUP#5 · 21,150 sh | 21,150 | $15.2K | 0.00% | 0.0% |
| 6 | Pathstone#6 · 16,528 sh | 16,528 | $11.9K | 0.00% | 0.0% |
| 7 | GEODE CAPITAL MANAGEMENT#7 · 15,870 sh | 15,870 | $11.4K | 0.00% | 0.0% |
| 8 | XTX Topco Ltd#8 · 11,473 sh | 11,473 | $8.3K | <0.01% | New |
| 9 | Creative Planning#9 · 11,410 sh | 11,410 | $8.2K | 0.00% | -4.2% |
| 10 | HRT FINANCIAL#10 · 10,515 sh | 10,515 | $7.0K | 0.00% | New |
| 11 | Empery Asset Management#11 · 100,402 sh | 100,402 | $6.3K | <0.01% | 0.0% |
| 12 | Clear Street Group#12 · 63,085 sh | 63,085 | $4.0K | 0.00% | -0.5% |
| 13 | JONES FINANCIAL COMPANIES LLLP#13 · 1,000 sh | 1,000 | $757.00 | 0.00% | 0.0% |
| 14 | SBI Securities , Ltd.#14 · 255 sh | 255 | $184.00 | — | -3.8% |
Funds that sold out of NRSN in Q2 2026 (3)
Held NRSN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| TWO SIGMA INVESTMENTS44,445 sh | 44,445 | $33.6K |
| MEITAV INVESTMENT HOUSE LTD40,000 sh | 40,000 | $30.2K |
| JANE STREET GROUP28,670 sh | 28,670 | $21.6K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.